Skip to main content
. 2022 Apr 22;6(2):zrac030. doi: 10.1093/bjsopen/zrac030

Table 4.

Treatment of the endoluminal vacuum therapy

Total
n (%)
AL
n (%)
Perforation
n (%)
102 (100) 69 (67.6) 33 (33.4)
Treatment started within 24 h
 Yes 92 (90.2) 65.3 (92.8) 28 (84.9)
 No 10 (8.9) 5 (7.2) 5 (15.1)
Treatment type
 Intraluminal and intracavitary 50 (49) 33 (47.8) 17 (51.5)
 Intracavitary 27 (26.5) 22 (31.9) 5 (15.2)
 Intraluminal 25 (24.5) 14 (20.3) 11 (33.3)
Intensive care unit
 Yes 74 (72.6) 52 (75.4) 22 (66.7)
 No 28 (27.5) 17 (24.6) 11 (33.3)
Additional thoracic/pleural drainage
 None 55 (53.9) 33 (47.8) 22 (66.7)
 Thoracic drainage 41 (40.2) 34 (49.3) 7 (21.2)
 Thoracic drainage lavage 6 (5.9) 2 (2.9) 4 (12.2)
Feeding type
 Jejunal/enteral 49 (48) 47 (68.1) 2 (6.1)
 Enteral feeding tube/enteral 28 (27.5) 17 (24.6) 11 (33.3)
 Parenteral 20 (19.6) 3 (4.4) 17 (51.5)
 PEG/enteral 3 (2.9) 1 (1.5) 2 (6.1)
Dysphagia score
 0, no dysphagia: able to eat normal diet 77 (75.5) 54 (78.3) 23 (69.7)
 1, moderate passage: able to eat some solid foods 18 (17.7) 10 (14.5) 8 (24.2)
 2, poor passage: able to eat semi-solid foods 6 (5.9) 4 (5.8) 2 (6.1)
 3, very poor passage: able to swallow liquids only 1 (1) 1 (1.5) n.a.

AL, anastomotic leakage; PEG, percutaneous endoscopic gastrostomy.